For silencing the MECP2 in the neuroblastoma cells, the efficacy of the siRNA at two different concentrations, 5 and 200 nM, were assessed using PCR analysis and immunohistochemical staining (Figures 3A,B). Here, MECP2 is linked to neuroblastoma.